P. R. Sundaresan

Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics

Chetan Lathia, John Lettieri, Frank Cihon et al. · Cancer Chemotherapy and Pharmacology · 2005 · 207 citations

Sorafenib Clinical Pharmacokinetics, Medicine, Clinical Pharmacology +5

Long-term weight control study I (weeks 0 to 34)

Michael Weintraub, P. R. Sundaresan, Manish Madan et al. · Clinical Pharmacology & Therapeutics · 1992 · 172 citations

Sympathetic neural modulation of the immune system

Kelley S. Madden, Suzanne Y. Felten, David L. Felten et al. · Brain Behavior and Immunity · 1989 · 165 citations

The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease

Udho Thadani, William Smith, Stephen Nash et al. · Journal of the American College of Cardiology · 2002 · 147 citations

Selective Phosphodiesterase-5 Inhibitor, Cardiovascular Disease, Erectile Dysfunction +9

Effect of High‐Fat Breakfast and Moderate‐Fat Evening Meal on the Pharmacokinetics of Vardenafil, an Oral Phosphodiesterase‐5 Inhibitor for the Treatment of Erectile Dysfunction

Prabhu Rajagopalan, Arthur Mazzu, Chenghua Xia et al. · The Journal of Clinical Pharmacology · 2003 · 108 citations